Results of an on-line survey of patients with hereditary angioedema

Allergy and Asthma Proceedings

Volumn 25, Issue 2, 2004, Pages 127-131

  Huang, Shih Wen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; EMERGENCY WARD; HEALTH SURVEY; HUMAN; ONLINE SYSTEM; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANGIONEUROTIC EDEMA; CLINICAL COMPETENCE; EMERGENCY SERVICE, HOSPITAL; FEAR; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INTERNET; MALE; PATIENT SATISFACTION; UNITED STATES;

EID: 2442532954     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Sheffer AL, Fearon DT, and Austen KF. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J Allergy Clin Immunol 68:181-187, 1981.
2. Cavagni G, Giovane A, and Vierucci A. Anaphylaxis in children: clinical and allergologic features. Pediatrics 101:E8, 1998.
3. Wuthrich B, Devay J, and Spath P. Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor - a still unfamiliar disease picture. Schweiz Med Wochenschr 129:285-291, 1999.
4. Lin Ry, Curry A, Pesola GR, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emer Med 36:462-468, 2000.
5. Charlesworth EN. Chronic urticaria: background evaluation and treatment. Curr Allergy Asthma Rep 1:342-347, 2001.
6. Zuraw BL, and Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J Allergy Clin Immunol 105: 541-546, 2000.
7. Zahedi R, MacFarlene RC, Wisnieski JJ, and Davis A III. C1 inhibitor: Analysis of the role of amino acid residues within the reactive center loop in target protease recognition. J Immunol 167:1500-1506, 2001.
8. Bowen B, Hawk JJ, Sibunka S, et al. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin Immunol 98:157-163, 2001.
9. Ruddy S. Hereditary angioedema undersuspected, underdiagnosed. Hosp Prac 23:91-106, 1988.
10. Bork K, Bernstedt S-E, Koch P, and Taupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213-217, 2000.
11. Brinkley KE, and Davis A III. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106:546-550, 2000.
12. Bork K, and Barnstedt SE. treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 161:714-718, 2001.
13. Krischfink M, and Mollnes TE. C1 inhibitor: an anti-inflammatory reagent with therapeutic potential. Expert Opin Pharmacother 2:1073-1083, 2001.